基本信息
views: 4
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Jasmine Luzum’s (formerly Talameh) research focuses on the improvement of pharmacologic outcomes and reduction of racial disparities in patients with cardiovascular disease, especially heart failure. She uses a variety of clinical & translational research approaches, with an emphasis on pharmacogenomics. Her research has been funded by the most prestigious sponsors, published in top journals, and presented at major conferences.
Research Interests
Papers共 70 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Ana I Lopez-Medina,Alessandra M Campos-Staffico,Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby,Omer Berenfeld,Jasmine A Luzum
Pharmacogenomicsno. 3 (2024): 117-131
Ana Lopez Medina,Alessandra M. Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P. Jacoby, Mohammed Saeed,Omer Berenfeld,Jasmine A. Luzum
Journal of Clinical and Translational Scienceno. s1 (2024): 140-140
Research and Practice in Thrombosis and Haemostasisno. 1 (2024): 102285-102285
Naveen L Pereira, Sharon Cresci, Dominick J Angiolillo,Wayne Batchelor, Quinn Capers,Larisa H Cavallari, Dana Leifer,Jasmine A Luzum, Dan M Roden, Konstantinos Stellos, Stephanie L Turrise,Sony Tuteja,
Circulation (2024)
Side Effects of Drugs Annual (2023): XXVII-LVI
CLINICAL PHARMACOLOGY & THERAPEUTICSno. 4 (2023): 762-767
Circulation. Genomic and precision medicineno. 2 (2023): e003835-e003835
GENESno. 11 (2023): 2019
Journal of the American College of Cardiologyno. 8 (2023): 435-435
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn